Lutris Pharma to Present Updated Data from Its Phase 2 Trial of LUT014 Gel for the Treatment of Patients With EGFRI-Induced Acneiform Rash at the EADV CongressSeptember 16, 2026
Nitinotes Announces First EASE™ Clinical Trial Procedures at Fondazione Policlinico Universitario Agostino Gemelli IRCCS in ItalySeptember 15, 2026
Airway Therapeutics Closes $50 Million Equity Round to Advance Late-Stage Development of Zelpultide AlfaAugust 25, 2026 The capital raise supports ongoing Phase 2b/3 clinical trial for prevention of bronchopulmonary dysplasia and associated CMC and analytical activitiesApproximately…
